![Cynthia Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 804 510 $ in data 31/07/2026
Cynthia Smith is currently an Independent Director at Agios Pharmaceuticals, Inc. since 2022, Akebia Therapeutics, Inc. since 2018, Spero Therapeutics, Inc. since 2019, Protara Therapeutics, Inc. since 2021, and Tvardi Therapeutics, Inc. starting in 2025.
Ms. Smith is also a Director at the French-American Foundation.
Former positions include Executive Director-Healthcare System at Merck & Co., Inc. from 2000 to 2008, Independent Director at Dicerna Pharmaceuticals, Inc. from 2018 to 2021, Independent Director at Nivalis Therapeutics, Inc. from 2016 to 2017, Chief Commercial Officer at ZS Pharma, Inc. from 2013 to 2016, and VP-Market Access & Commercial Development at Affymax, Inc. from 2008 to 2013.
Education includes undergraduate studies at The University of North Carolina at Chapel Hill, an MBA from The Wharton School of the University of Pennsylvania, and graduate studies at the Eagleton Institute of Politics.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/06/2026 | 15.230 ( 0,03% ) | 457 205 $ | 31/07/2026 | |
| 17/06/2026 | 196.633 ( 0,07% ) | 259 556 $ | 31/07/2026 | |
| 23/06/2026 | 75.000 ( 0,13% ) | 87 750 $ | 31/07/2026 | |
| 15/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 | |
-.--% | 09/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 28/08/2018 |
| SPERO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 19/03/2019 |
| PROTARA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/01/2021 |
| AGIOS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 11/08/2022 |
French-American Foundation
 French-American Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a non profit organization for social services | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 28/12/2021 |
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Direttore/Membro del Consiglio | 01/07/2017 |
| ZS PHARMA INC | Corporate Officer/Principal | 01/12/2016 |
| AFFYMAX, INC. | Corporate Officer/Principal | 01/03/2013 |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
ZS Pharma, Inc.
 ZS Pharma, Inc. BiotechnologyHealth Technology Develops develop new treatments of kidney and liver diseases | Health Technology |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
French-American Foundation
French-American Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a non profit organization for social services | Miscellaneous |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Health Technology |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eagleton Institute of Politics
 Eagleton Institute of Politics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protara Therapeutics, Inc.
 Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
